412 related articles for article (PubMed ID: 20189943)
41. Antibacterial properties of larval secretions of the blowfly, Lucilia sericata.
Kerridge A; Lappin-Scott H; Stevens JR
Med Vet Entomol; 2005 Sep; 19(3):333-7. PubMed ID: 16134984
[TBL] [Abstract][Full Text] [Related]
42. A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.
Bauer J; Siala W; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2013 Jun; 57(6):2726-37. PubMed ID: 23571532
[TBL] [Abstract][Full Text] [Related]
43. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
Sader HS; Becker HK; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2010 Mar; 66(3):329-31. PubMed ID: 20159377
[TBL] [Abstract][Full Text] [Related]
44. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.
Torrico M; Giménez MJ; González N; Alou L; Sevillano D; Cafini F; Prieto J; Cleeland R; Aguilar L
Int J Antimicrob Agents; 2010 Feb; 35(2):131-7. PubMed ID: 20006469
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
Appleman MD; Citron DM
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
[TBL] [Abstract][Full Text] [Related]
46. Daptomycin is effective as antibiotic-lock therapy in a model of Staphylococcus aureus catheter-related infection.
Meije Y; Almirante B; Del Pozo JL; Martín MT; Fernández-Hidalgo N; Shan A; Basas J; Pahissa A; Gavaldà J
J Infect; 2014 Jun; 68(6):548-52. PubMed ID: 24412247
[TBL] [Abstract][Full Text] [Related]
47. Effects of tea tree (Melaleuca alternifolia) oil on Staphylococcus aureus in biofilms and stationary growth phase.
Kwieciński J; Eick S; Wójcik K
Int J Antimicrob Agents; 2009 Apr; 33(4):343-7. PubMed ID: 19095413
[TBL] [Abstract][Full Text] [Related]
48. Combined efficacy of clarithromycin plus cefazolin or vancomycin against Staphylococcus aureus biofilms formed on titanium medical devices.
Fujimura S; Sato T; Mikami T; Kikuchi T; Gomi K; Watanabe A
Int J Antimicrob Agents; 2008 Dec; 32(6):481-4. PubMed ID: 18790609
[TBL] [Abstract][Full Text] [Related]
49. D-amino acids enhance the activity of antimicrobials against biofilms of clinical wound isolates of Staphylococcus aureus and Pseudomonas aeruginosa.
Sanchez CJ; Akers KS; Romano DR; Woodbury RL; Hardy SK; Murray CK; Wenke JC
Antimicrob Agents Chemother; 2014 Aug; 58(8):4353-61. PubMed ID: 24841260
[TBL] [Abstract][Full Text] [Related]
50. In vitro susceptibility to antibiotics of staphylococci in biofilms isolated from orthopaedic infections.
Molina-Manso D; del Prado G; Ortiz-Pérez A; Manrubia-Cobo M; Gómez-Barrena E; Cordero-Ampuero J; Esteban J
Int J Antimicrob Agents; 2013 Jun; 41(6):521-3. PubMed ID: 23611308
[TBL] [Abstract][Full Text] [Related]
51. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
[TBL] [Abstract][Full Text] [Related]
52. Detection and partial characterisation of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA).
Bexfield A; Nigam Y; Thomas S; Ratcliffe NA
Microbes Infect; 2004 Nov; 6(14):1297-304. PubMed ID: 15555536
[TBL] [Abstract][Full Text] [Related]
53. Extended antimicrobial susceptibility assay for Staphylococcus aureus isolates from bovine mastitis growing in biofilms.
Melchior MB; Fink-Gremmels J; Gaastra W
Vet Microbiol; 2007 Nov; 125(1-2):141-9. PubMed ID: 17600640
[TBL] [Abstract][Full Text] [Related]
54. In vitro antibacterial activity of Lucilia sericata maggot secretions.
Daeschlein G; Mumcuoglu KY; Assadian O; Hoffmeister B; Kramer A
Skin Pharmacol Physiol; 2007; 20(2):112-5. PubMed ID: 17167275
[TBL] [Abstract][Full Text] [Related]
55. A model for testing drug susceptibility of Pseudomonas aeruginosa and Staphylococcus aureus grown in biofilms on medical devices.
Kétyi I
Acta Microbiol Immunol Hung; 1995; 42(2):215-9. PubMed ID: 7551716
[TBL] [Abstract][Full Text] [Related]
56. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms.
Lee CK; Rubin LG; Moldwin RM
Urology; 1995 Apr; 45(4):720-4. PubMed ID: 7716861
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study.
Eick S; Seltmann T; Pfister W
J Clin Periodontol; 2004 May; 31(5):376-83. PubMed ID: 15086620
[TBL] [Abstract][Full Text] [Related]
58. Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.
Gerber P; Stucki A; Acosta F; Cottagnoud M; Cottagnoud P
J Antimicrob Chemother; 2006 Apr; 57(4):720-3. PubMed ID: 16459345
[TBL] [Abstract][Full Text] [Related]
59. Antimicrobial activities of YycG histidine kinase inhibitors against Staphylococcus epidermidis biofilms.
Qin Z; Lee B; Yang L; Zhang J; Yang X; Qu D; Jiang H; Molin S
FEMS Microbiol Lett; 2007 Aug; 273(2):149-56. PubMed ID: 17578527
[TBL] [Abstract][Full Text] [Related]
60. Effects of vancomycin, daptomycin, and tigecycline on coagulase-negative staphylococcus biofilm and bacterial viability within biofilm: an in vitro biofilm model.
Ozturk B; Gunay N; Ertugrul BM; Sakarya S
Can J Microbiol; 2016 Sep; 62(9):735-43. PubMed ID: 27295353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
